Literature DB >> 35655349

Reasoning is to be welcomed.

Günther Egidi.   

Abstract

Entities:  

Year:  2022        PMID： 35655349      PMCID： PMC9229582          DOI： 10.3238/arztebl.m2022.0047

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   8.251


× No keyword cloud information.
  2 in total

1.  Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Authors:  Sonia S Anand; Jackie Bosch; John W Eikelboom; Stuart J Connolly; Rafael Diaz; Peter Widimsky; Victor Aboyans; Marco Alings; Ajay K Kakkar; Katalin Keltai; Aldo P Maggioni; Basil S Lewis; Stefan Störk; Jun Zhu; Patricio Lopez-Jaramillo; Martin O'Donnell; Patrick J Commerford; Dragos Vinereanu; Nana Pogosova; Lars Ryden; Keith A A Fox; Deepak L Bhatt; Frank Misselwitz; John D Varigos; Thomas Vanassche; Alvaro A Avezum; Edmond Chen; Kelley Branch; Darryl P Leong; Shrikant I Bangdiwala; Robert G Hart; Salim Yusuf
Journal:  Lancet       Date:  2017-11-10       Impact factor: 79.321

Review 2.  Antithrombotic Treatment for Peripheral Arterial Occlusive Disease.

Authors:  David Hardung; Andrea Behne; Mehmet Boral; Carsten Giesche; Ralf Langhoff
Journal:  Dtsch Arztebl Int       Date:  2021-08-09       Impact factor: 8.251
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.